otricath
NHC, LLC develops the Otricath™, a medical device that offers a minimally invasive, controlled, and localized method for delivering therapeutic agents, particularly in cancer treatment. The company's mission is to improve patient outcomes by providing innovative catheter-based solutions that maximize therapeutic efficacy while minimizing systemic side effects. Their vision is to advance medical technology through collaborative and adaptable platform solutions, enabling a wide range of applications in oncology, cardiovascular disease, and drug testing.
Industries
Nr. of Employees
small (1-50)
otricath
Products
Three-part catheter system for localized closed-loop venous infusion and withdrawal
A catheter system composed of an infusion catheter, an occlusion balloon, a central pressure-monitoring catheter, and a suction catheter designed to create an isolated venous treatment zone for localized delivery and concurrent withdrawal of therapeutic agents.
Three-part catheter system for localized closed-loop venous infusion and withdrawal
A catheter system composed of an infusion catheter, an occlusion balloon, a central pressure-monitoring catheter, and a suction catheter designed to create an isolated venous treatment zone for localized delivery and concurrent withdrawal of therapeutic agents.
Services
Preclinical pilot in‑vivo device testing and protocol development
Collaborative pilot studies establishing catheterization techniques, infusion/withdrawal protocols, sampling schedules, and pharmacokinetic analysis in an in‑vivo model to validate localized delivery performance.
Prototype bench testing and catheter component development
Bench testing of suction and infusion catheter components and development of infusion and central monitoring catheters progressing toward production.
Preclinical pilot in‑vivo device testing and protocol development
Collaborative pilot studies establishing catheterization techniques, infusion/withdrawal protocols, sampling schedules, and pharmacokinetic analysis in an in‑vivo model to validate localized delivery performance.
Prototype bench testing and catheter component development
Bench testing of suction and infusion catheter components and development of infusion and central monitoring catheters progressing toward production.
Expertise Areas
- Localized vascular drug delivery
- Interventional catheter device design
- Image-guided interventional procedures
- In‑vivo pharmacokinetics and tissue sampling
Key Technologies
- Fluoroscopy-guided intervention
- Dyna CT imaging
- Magnetic resonance imaging (MRI) guidance
- Balloon occlusion catheters